Sanofi-Aventis says gets US approval for Genzyme bid
Wednesday, October 20, 2010 - 10:31
in Mathematics & Economics
French pharmaceutical giant Sanofi-Aventis said on Wednesday that US competition authorities had not raised any objections to its hostile bid for US biotechnology group and rare disease specialist Genzyme.